120 HOLBORN, LONDON, EC1N 2DY, ENGLAND
- Tel:
- Work 020 7269 8500
- Fax:
- Fax 020 7269 8555
- DX:
- 0078 LONDON/CHANCERY LN
- Web:
- www.dyoung.com
- Email:
Dr Zöe Clyde-watson
- Tel:
- Work +44 20 7269 8550
- Email:
Work Department
Patents - biotechnology, chemistry and pharmaceuticals group.
Position
Zöe's area of expertise is chemistry, including small molecule pharmaceutical and veterinary chemistry. She also handles subject matter relating to therapeutic/diagnostic methods, process chemistry, antisense RNA technology, polymers, polymorphs and formulation chemistry. Zöe's clients include academic/research institutes, start-up companies, biotech/pharmaceutical SMEs and larger blue chip companies. Zöe's practice involves drafting, prosecution, oppositions and appeals and freedom to operate opinion work. Zöe also regularly advises small clients on IP due diligence for project acquisitions, investment/licensing opportunities and stock market flotations. Zöe heads up the Cyclacel team, and has been handling their patent portfolio for over 12 years. With Cyclacel, Zöe is involved with ongoing due diligence activities, prosecution, drafting and opposition work. Zöe also continues to manage Amura's patent portfolio. Together with Charles Harding, Zöe handles Merial chemical work (prosecution and opposition). Zöe and Chareles are advising Merial on a pan-European litigation relating to Frontline and Frontline Plus (veterinary products for treating fleas in cats and dogs). Along with Charles Harding, Zöe is involved with several pending opposition/appeal cases for Santaris A/S relating to their core antisense RNA technology. Zöe continues to handle xenon-related technology for Air Products by way of prosecution, opposition and appeal work. Zöe also acts for academic institutions and has published articles on pharma-academic partnerships. Zöe's other clients include Bergen Teknologioverforing AS, and Eldrug, a Greek pharmaceutical start up company. Zöe also handles medicinal chemistry work for the Medical Research Council and polymer work for Revolymer Ltd. A new addition to her portfolio is the University of Manchester (UMIP), following D Young & Co's appointment to their panel of providers. Zöe heads up the UMIP team and coordinates drafting, filing and prosecution across the full range of technical disciplines.
Career
European patent attorney 2002; chartered patent attorney 2002. Zöe joined D Young & Co in 1998, partner 2004. Publications of note: 'Ethyne-linked cyclic porphyrin oligomers: Synthesis and binding properties', J. Org. Chem., 1997, 62,240.
Member
Chartered Institute of Patent Attorneys (CIPA); European Patent Institute (epi).
Education
St Catharine's College, University of Cambridge (MA in Natural Sciences; PhD in organic chemistry - research into porphyrin-based receptors, their synthesis and intracavity chemistry); Queen Mary College, University of London (Certificate in Intellectual Property Law).
